Recent Articles by

The cutting-edge research identifies weaknesses in dangerous C. difficile bacteria.

Scientists are urging further studies to better understand the drugs’ long-term effects in patients.

The international team, which includes a UVA researcher, is emphasizing cocktails of two or more drugs that people could take at home at the first sign of infection.

They’re more likely to screen for breast than colorectal cancer. But why?

The findings suggest a way to help patients heal from life-threatening C. difficile infections.

The unexpected connection could open door to new treatments.

Researchers are testing a new virtual reality system that they say is far more practical for budding drivers than a room-sized simulator located in a lab on Grounds.

The noninvasive alternative shows potential for treating epilepsy and could benefit other common neurological diseases.

The pioneering UVA research provides new options for Parkinson’s patients.

The drug could prove particularly important for the immunocompromised, UVA researchers said.